(Q40795436)

23 September 2017

Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controls (English)

1 reference

myeloproliferative neoplasm

23 September 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113113%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Amylou Dueck

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113113%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Frank de Vocht

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113113%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Glen James

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113113%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Andrew S Duncombe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113113%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Ruben Mesa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113113%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Robyn Scherber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113113%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Mike Clarke

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113113%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Mary F McMullin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113113%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

1 reference

25 June 2015

1 reference

American Journal of Hematology

23 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113113%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113113%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113113%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

864-870

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113113%20AND%20SRC:MED&resulttype=core&format=json

How common are myeloproliferative neoplasms? A systematic review and meta-analysis.

13 June 2020

cites work

1 reference

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

21 January 2018

1 reference

Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs

21 January 2018

1 reference

Symptom burden and splenomegaly in patients with myelofibrosis in the United States: a retrospective medical record review

21 January 2018

1 reference

Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts.

21 January 2018

1 reference

Therapy for myeloproliferative neoplasms: when, which agent, and how?

21 January 2018

1 reference

Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms

21 January 2018

1 reference

Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms.

21 January 2018

1 reference

Fatigue in primary care: longitudinal associations with pain

21 January 2018

1 reference

Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report

21 January 2018

1 reference

Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study

21 January 2018

1 reference

Comprehensive review of JAK inhibitors in myeloproliferative neoplasms.

21 January 2018

1 reference

Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AJH.24098

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113113%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference